Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

04-09-2015 | Uitgave 2/2016

Quality of Life Research 2/2016

Empirical validation of the English version of the Fear of Cancer Recurrence Inventory

Tijdschrift:
Quality of Life Research > Uitgave 2/2016
Auteurs:
Sophie Lebel, Sebastien Simard, Cheryl Harris, Andrea Feldstain, Sara Beattie, Megan McCallum, Monique Lefebvre, Josée Savard, Gerald M. Devins
Belangrijke opmerkingen
Requests for permission to use the FCRI (French or English versions) should be addressed to Sébastien Simard: Sebastien.Simard@criucpq.ulaval.ca.

Abstract

Purpose

Cancer patients report that help in managing fear of cancer recurrence (FCR) is one of their greatest unmet needs. Research on FCR has been limited by the very few validated, multi-dimensional measures of this construct. One exception is the Fear of Cancer Recurrence Inventory (FCRI), originally developed and empirically validated in French. The present study validated the English version of the FCRI.

Methods

The FCRI was translated into English using a forward–backward translation procedure and pilot-tested with 17 English-speaking cancer patients. Cross-cultural equivalency of the French and English versions was established by administering both forms to 42 bilingual cancer patients. Last, 350 English-speaking breast, colon, prostate, or lung cancer patients were asked to complete the FCRI. A subsample (n = 135) was mailed the FCRI again one month later to evaluate test–retest reliability.

Results

The English translation of the FCRI was well accepted by participants. There was no item-bias when comparing bilingual participants’ answers on both versions. A confirmatory factor analysis supported the hypothesized seven-factor structure. The English version has high internal consistency (α = .96 for the total scale and .71–.94 for the subscales) and test–retest reliability (r = .88 for the total scale and 56–.87 for the subscales).

Conclusions

The English version of the FCRI is a reliable and valid measure of FCR applicable to breast, colon, prostate, and lung cancer patients. Its multi-dimensional nature makes it an attractive research and clinical tool to further our knowledge of FCR.

Log in om toegang te krijgen

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Podotherapeut Totaal

Binnen de bundel kunt u gebruik maken van boeken, tijdschriften, e-learnings, web-tv's en uitlegvideo's. BSL Podotherapeut Totaal is overal toegankelijk; via uw PC, tablet of smartphone.

Literatuur
Over dit artikel

Andere artikelen Uitgave 2/2016

Quality of Life Research 2/2016 Naar de uitgave